Global cancer burden attributable to tobacco smoking in 2022: a differential analysis by smoking status, sex, and development level
Abstract
Background: Tobacco smoking is a leading preventable cause of cancer. We estimated its attributable cancer burden by smoking status (current vs. former), further stratified by cancer type, sex, country, and Human Development Index (HDI).
Methods: The Population Attributable Fraction (PAF) for cancer incidence and mortality due to tobacco were estimated across 175 countries by using 2000 Global Burden of Disease smoking prevalence and 2022 Global Cancer Observatory cancer data. Relative risks (RRs) were derived from large pooled and meta-analyses, and population data from the World Bank. Countries were categorized by HDI.
Results: The global tobacco PAF was 17.2% for cancer incidence and 22.4% for mortality. Lung cancer had the highest RR for current smokers (8.96) and laryngeal cancer for former smokers (4.65). Males had a higher cancer incidence (26.1%) and mortality (32.1%) burden than females (8.0% and 10.2%, respectively). Cancers with the highest smoking PAF were laryngeal (70.1%), lung (66.9%), pharyngeal (63.5%), oral cavity (38.5%), and bladder (39.4%). PAF estimates for incidence were 5.4% in low-HDI (49 countries), 15.0% in medium-HDI [41], 19.3% in high-HDI [32], and 17.4% in very-high-HDI [32] countries; corresponding mortality estimates were 6.4% (low-HDI), 17.4% (medium-HDI), 26.0% (high-HDI), and 23.6% (very-high-HDI), respectively.
Conclusion: Approximately one in six cancer cases and one in four cancer deaths globally are attributable to tobacco smoking. Despite declining smoking prevalence, former smokers account for a substantial burden long after cessation. Males and higher-HDI countries bear a greater burden.
Related
- Tobacco-attributable mortality and disease burden in India: a descriptive analysis of Global Burden of Disease 2023 estimates for 1990 and 2023
- Cancer incidence and mortality attributable to active smoking and second-hand smoke exposure in China, 2019: an attributable-risk analysis
- Smoking-Attributable Mortality in China — Epidemic Stage as a Temporal Dimension in Interpreting GBD Estimates
- Tobacco-attributable burden of alzheimer’s disease and other dementias in China and ASEAN : Temporal trends and projections – an observational study based on GBD 2021
- Current tobacco use and associated factors among school-going adolescents in the Republic of Congo: Secondary analysis of the 2019 Global Youth Tobacco Survey and development of a simple identification score
BibTeX
@article{shah2026global,
title = {{Global cancer burden attributable to tobacco smoking in 2022: a differential analysis by smoking status, sex, and development level}},
author = {Veer Shah and Darshi Shah and Karan Shah and Jeanne Wu and Daniele Bruno and Paolo Boffetta and Monireh Sadat Seyyedsalehi},
journal = {International Journal of Epidemiology},
year = {2026},
month = nov,
doi = {10.1093/ije/dyag239},
url = {https://doi.org/10.1093/ije/dyag239},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Global cancer burden attributable to tobacco smoking in 2022: a differential analysis by smoking status, sex, and development level
AU - Veer Shah
AU - Darshi Shah
AU - Karan Shah
AU - Jeanne Wu
AU - Daniele Bruno
AU - Paolo Boffetta
AU - Monireh Sadat Seyyedsalehi
PY - 2026
DA - 2026/11/06
JO - International Journal of Epidemiology
DO - 10.1093/ije/dyag239
UR - https://doi.org/10.1093/ije/dyag239
AB - Background: Tobacco smoking is a leading preventable cause of cancer. We estimated its attributable cancer burden by smoking status (current vs. former), further stratified by cancer type, sex, country, and Human Development Index (HDI). Methods: The Population Attributable Fraction (PAF) for cancer incidence and mortality due to tobacco were estimated across 175 countries by using 2000 Global Burden of Disease smoking prevalence and 2022 Global Cancer Observatory cancer data. Relative risks (RRs) were derived from large pooled and meta-analyses, and population data from the World Bank. Countries were categorized by HDI. Results: The global tobacco PAF was 17.2% for cancer incidence and 22.4% for mortality. Lung cancer had the highest RR for current smokers (8.96) and laryngeal cancer for former smokers (4.65). Males had a higher cancer incidence (26.1%) and mortality (32.1%) burden than females (8.0% and 10.2%, respectively). Cancers with the highest smoking PAF were laryngeal (70.1%), lung (66.9%), pharyngeal (63.5%), oral cavity (38.5%), and bladder (39.4%). PAF estimates for incidence were 5.4% in low-HDI (49 countries), 15.0% in medium-HDI [41], 19.3% in high-HDI [32], and 17.4% in very-high-HDI [32] countries; corresponding mortality estimates were 6.4% (low-HDI), 17.4% (medium-HDI), 26.0% (high-HDI), and 23.6% (very-high-HDI), respectively. Conclusion: Approximately one in six cancer cases and one in four cancer deaths globally are attributable to tobacco smoking. Despite declining smoking prevalence, former smokers account for a substantial burden long after cessation. Males and higher-HDI countries bear a greater burden.
SN - 0300-5771
SN - 1464-3685
ER -